- Public Comps
- Camlin Fine Sciences
Camlin Fine Sciences Valuation Multiples
Discover Camlin Fine Sciences' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Trayal Korporacija, Avantium, Synthomer, Flugger Group and more.
Camlin Fine Sciences Overview
About Camlin Fine Sciences
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
Founded
1993
HQ

Employees
661
Website
Sectors
Financials (LTM)
EV
$278M
Valuation Multiples
Start free trialCamlin Fine Sciences Financials
Camlin Fine Sciences reported last 12-month revenue of $199M and EBITDA of $18M.
In the same LTM period, Camlin Fine Sciences generated $96M in gross profit, $18M in EBITDA, and $10M in net income.
Camlin Fine Sciences P&L
In the most recent fiscal year, Camlin Fine Sciences reported revenue of $179M and EBITDA of $11M.
Camlin Fine Sciences is profitable as of last fiscal year, with gross margin of 39%, EBITDA margin of 6%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
Camlin Fine Sciences Stock Performance
Camlin Fine Sciences has current market cap of $215M, and enterprise value of $278M.
Camlin Fine Sciences' stock price is $1.12.
Camlin Fine Sciences has an EPS (earnings per share) of $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $278M | $215M | -1.4% | - | - | - | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCamlin Fine Sciences Valuation Multiples
Camlin Fine Sciences trades at 1.4x EV/Revenue multiple, and 15.5x EV/EBITDA.
Camlin Fine Sciences Financial Valuation Multiples
As of August 14, 2026, Camlin Fine Sciences has market cap of $215M and EV of $278M.
Camlin Fine Sciences has a P/E ratio of 21.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Camlin Fine Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Camlin Fine Sciences Margins & Growth Rates
Camlin Fine Sciences grew revenue by 29% and EBITDA by 162% in the last fiscal year.
In the most recent fiscal year, Camlin Fine Sciences reported gross margin of 39%, EBITDA margin of 6%, and net margin of 2%.
Camlin Fine Sciences Margins
Camlin Fine Sciences Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Camlin Fine Sciences Operational KPIs
Camlin Fine Sciences' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Camlin Fine Sciences' Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Camlin Fine Sciences' Rule of X is 68% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Camlin Fine Sciences Competitors
Camlin Fine Sciences competitors include Trayal Korporacija, Avantium, Synthomer, Flugger Group, Hudson Technologies, Grupa Azoty Puławy, XRF Scientific, Solar Foods, Gurit Holding and H&R Gruppe.
Most Camlin Fine Sciences public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.1x | - | 124.4x | - | |||
| 19.0x | 8.7x | (15.5x) | (9.6x) | |||
| 0.5x | 0.5x | 16.4x | 5.7x | |||
| 0.8x | 0.8x | 6.7x | 6.6x | |||
| 0.9x | 0.8x | 8.9x | 9.6x | |||
| 0.2x | - | 35.7x | - | |||
| 4.3x | 3.8x | 15.2x | 14.2x | |||
| 1116.3x | 172.6x | (147.0x) | (65.1x) | |||
This data is available for Pro users. Sign up to see all Camlin Fine Sciences competitors and their valuation data. Start Free Trial | ||||||
Camlin Fine Sciences VC Funding History
Before going public, Camlin Fine Sciences raised $23M in total equity funding, across 1 round.
Camlin Fine Sciences Funding Rounds
Acquisitions by Camlin Fine Sciences
Camlin Fine Sciences has acquired 3 companies to date.
Last acquisition by Camlin Fine Sciences was on February 25th 2025. Camlin Fine Sciences acquired Vinpai for $15M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Camlin Fine Sciences
| Description | Vinpai SA is an ingredient tech that offers manufacturers natural alternatives to chemical additives. The Company is an ingredientist that designs, manufactures and markets complementary and ranges of functional ingredients based on algae, plants, minerals and fibers. These ingredients have the function of texturing, stabilizing, preserving, flavoring and/ or enriching the recipes of the food industry, cosmetics, well-being, and health. Vinpai offers manufacturers a complete offer including the supply of functional ingredients, sometimes combined in premix, as well as support for the formulation and the launch of industrial production with the management of the ramp-up with the transition from the lab to the factory. | Ningbo Wanglong Flavors and Fragrances Co. is a medium-sized Ningbo-based producer researching, developing, and manufacturing flavors and fragrances as food additives. The company handles import and export agency services for related goods and technologies in China. | Dresen Quimica S.A de C.V. is a Mexico-headquartered manufacturer of specialty chemical intermediates for animal feed, human food, and industrial applications. The company operates production facilities in Mexico, Guatemala, Peru, Colombia, and the Dominican Republic, supplying additives and preservatives to regional agribusinesses and manufacturers. |
| HQ Country | |||
| HQ City | - | Yuyao | Mexico City |
| Deal Date | 25 Feb 2025 | 25 Dec 2016 | 5 May 2016 |
| Valuation | $15M | $12M | $12M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Camlin Fine Sciences acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Camlin Fine Sciences
| When was Camlin Fine Sciences founded? | Camlin Fine Sciences was founded in 1993. |
| Where is Camlin Fine Sciences headquartered? | Camlin Fine Sciences is headquartered in India. |
| How many employees does Camlin Fine Sciences have? | As of today, Camlin Fine Sciences has over 661 employees. |
| Is Camlin Fine Sciences publicly listed? | Yes, Camlin Fine Sciences is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Camlin Fine Sciences? | Camlin Fine Sciences trades under CAMLINFINE ticker. |
| When did Camlin Fine Sciences go public? | Camlin Fine Sciences went public in 2015. |
| Who are competitors of Camlin Fine Sciences? | Camlin Fine Sciences main competitors include Trayal Korporacija, Avantium, Synthomer, Flugger Group, Hudson Technologies, Grupa Azoty Puławy, XRF Scientific, Solar Foods, Gurit Holding, H&R Gruppe. |
| What is the current market cap of Camlin Fine Sciences? | Camlin Fine Sciences' current market cap is $215M. |
| What is the current revenue of Camlin Fine Sciences? | Camlin Fine Sciences' last 12 months revenue is $199M. |
| What is the current revenue growth of Camlin Fine Sciences? | Camlin Fine Sciences revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Camlin Fine Sciences? | Current revenue multiple of Camlin Fine Sciences is 1.4x. |
| What is the current EBITDA of Camlin Fine Sciences? | Camlin Fine Sciences' last 12 months EBITDA is $18M. |
| What is Camlin Fine Sciences' EBITDA margin? | Camlin Fine Sciences' last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Camlin Fine Sciences? | Current EBITDA multiple of Camlin Fine Sciences is 15.5x. |
| What is the current FCF of Camlin Fine Sciences? | Camlin Fine Sciences' last 12 months FCF is ($3M). |
| What is Camlin Fine Sciences' FCF margin? | Camlin Fine Sciences' last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Camlin Fine Sciences? | Current FCF multiple of Camlin Fine Sciences is (83.4x). |
| How many companies Camlin Fine Sciences has acquired to date? | As of August 2026, Camlin Fine Sciences has acquired 3 companies. |
| What was the largest acquisition by Camlin Fine Sciences? | $15M acquisition of Vinpai on 25th February 2025 was the largest M&A Camlin Fine Sciences has done to date. |
| What companies Camlin Fine Sciences acquired? | Camlin Fine Sciences acquired Vinpai, Ningbo Wanglong Flavors and Fragrances Co., and Dresen Quimica S.A de C.V.. |
| In how many companies Camlin Fine Sciences has invested to date? | Camlin Fine Sciences hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Camlin Fine Sciences
Lists including Camlin Fine Sciences
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.







